Cargando…

Central effects of galcanezumab in migraine: a pilot study on Steady State Visual Evoked Potentials and occipital hemodynamic response in migraine patients

BACKGROUND: The discovery of the prominent action of Calcitonin Gene Related Peptide –CGRP- on trigeminal afferents and meningeal vessels, opened a new era in migraine treatment. However, how the block of nociceptive afferents could act on central mechanisms of migraine is still not clear. In this p...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Tommaso, Marina, La Rocca, Marianna, Quitadamo, Silvia Giovanna, Ricci, Katia, Tancredi, Giusy, Clemente, Livio, Gentile, Eleonora, Ammendola, Elena, Delussi, Marianna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Milan 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052688/ https://www.ncbi.nlm.nih.gov/pubmed/35484504 http://dx.doi.org/10.1186/s10194-022-01421-z

Ejemplares similares

Laser evoked potentials and central sensitization in migraine
por: Vecchio, Eleonora, et al.
Publicado: (2015)

Effects of OnabotulintoxinA on Habituation of Laser Evoked Responses in Chronic Migraine
por: de Tommaso, Marina, et al.
Publicado: (2016)

Effect of Single Session of Anodal M1 Transcranial Direct Current Stimulation—TDCS—On Cortical Hemodynamic Activity: A Pilot Study in Fibromyalgia
por: La Rocca, Marianna, et al.
Publicado: (2022)

Galcanezumab for migraine
Publicado: (2020)

N°282 – Observational study of frontal brain function involvement in post-Covid-19 patients
por: Clemente, Livio, et al.
Publicado: (2023)

Failure of preventive treatments in migraine: an observational retrospective study in a tertiary headache center
por: Delussi, Marianna, et al.
Publicado: (2020)

P042. Mechanism of action and clinical evidence of botulinum toxin in chronic migraine
por: Franco, Giovanni, et al.
Publicado: (2015)

An Evidence-Based Review of Galcanezumab for the Treatment of Migraine
por: Urits, Ivan, et al.
Publicado: (2020)

Photophobia and migraine outcome during treatment with galcanezumab
por: Schiano di Cola, Francesca, et al.
Publicado: (2023)

One-Time Use of Galcanezumab or Fremanezumab for Migraine Prevention
por: Katsuki, Masahito, et al.
Publicado: (2023)

Circadian rhythms of migraine attacks in episodic and chronic patients: a cross sectional study in a headache center population
por: de Tommaso, Marina, et al.
Publicado: (2018)

Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine
por: Ament, Michael, et al.
Publicado: (2021)

Migraine Disability Improvement during Treatment with Galcanezumab in Patients with Chronic and High Frequency Episodic Migraine
por: di Cola, Francesca Schiano, et al.
Publicado: (2023)

The Role of Galcanezumab in Migraine Prevention: Existing Data and Future Directions
por: Gklinos, Panagiotis, et al.
Publicado: (2021)

Assessment of C Fibers Evoked Potentials in Healthy Subjects by Nd : YAP Laser
por: Ammendola, Elena, et al.
Publicado: (2022)

Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies
por: Bangs, Mark E., et al.
Publicado: (2020)

Correction to: Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine
por: Ament, Michael, et al.
Publicado: (2021)

Two randomized migraine studies of galcanezumab: Effects on patient functioning and disability
por: Ford, Janet H., et al.
Publicado: (2019)

Efficacy and Safety of Galcanezumab for the Preventive Treatment of Migraine: A Narrative Review
por: Martin, Vincent, et al.
Publicado: (2020)

Erenumab and galcanezumab in chronic migraine prevention: effects after treatment termination
por: Raffaelli, Bianca, et al.
Publicado: (2019)

Early Onset and Maintenance Effect of Galcanezumab in Japanese Patients with Episodic Migraine
por: Igarashi, Hisaka, et al.
Publicado: (2021)

Correction to: Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies
por: Bangs, Mark E., et al.
Publicado: (2020)

Effects of Botulinum Toxin on Migraine Attack Features in Chronic Migraine: A Six-Month Open-Label Observation Study through Electronic Diary Smartphone Application
por: Santoro, Antonio, et al.
Publicado: (2019)

Serum levels of N-acetyl-aspartate in migraine and tension-type headache
por: de Tommaso, Marina, et al.
Publicado: (2012)

Galcanezumab in chronic migraine: The randomized, double-blind, placebo-controlled REGAIN study
por: Detke, Holland C., et al.
Publicado: (2018)

Response to Misused and Misleading: 100% Response Rate to Galcanezumab in Patients With Episodic Migraine
por: Rosen, Noah, et al.
Publicado: (2019)

Rapid Onset of Effect of Galcanezumab for the Prevention of Episodic Migraine: Analysis of the EVOLVE Studies
por: Detke, Holland C., et al.
Publicado: (2019)

Real-world evidence of galcanezumab for migraine treatment in Japan: a retrospective analysis
por: Takizawa, Tsubasa, et al.
Publicado: (2022)

Predictors of galcanezumab response in a real-world study of Korean patients with migraine
por: Kim, Seung Ae, et al.
Publicado: (2023)

Galcanezumab Effects on Migraine Severity and Symptoms in Japanese Patients with Episodic Migraine: Secondary Analysis of a Phase 2 Randomized Trial
por: Igarashi, Hisaka, et al.
Publicado: (2022)

Galcanezumab in migraine prevention: a systematic review and meta-analysis of randomized controlled trials
por: Gklinos, Panagiotis, et al.
Publicado: (2020)

Assessment of immunogenicity from galcanezumab phase 3 trials in patients with episodic or chronic migraine
por: Martinez, James M, et al.
Publicado: (2020)

Efficacy and safety of galcanezumab for preventive treatment of migraine: a systematic review and meta-analysis
por: Zhao, Xiuyuan, et al.
Publicado: (2020)

Improving distress perception and mutuality in migraine caregivers after 6 months of galcanezumab treatment
por: Fofi, Luisa, et al.
Publicado: (2022)

Abstract: Occipital Migraine: A Vascular Approach
por: Raposio, Edoardo, et al.
Publicado: (2017)

Motor Cortex Function in Fibromyalgia: A Study by Functional Near-Infrared Spectroscopy
por: Gentile, Eleonora, et al.
Publicado: (2019)

Pain Processing and Vegetative Dysfunction in Fibromyalgia: A Study by Sympathetic Skin Response and Laser Evoked Potentials
por: de Tommaso, Marina, et al.
Publicado: (2017)

Migraine Headache Day Response Rates and the Implications to Patient Functioning: An Evaluation of 3 Randomized Phase 3 Clinical Trials of Galcanezumab in Patients With Migraine
por: Ford, Janet H., et al.
Publicado: (2020)

Magnetic Resonance Imaging (MRI) and Visual Evoked Potentials (VEPs) of Occipital Region in Patients with Schizophrenia and Migraine Headache
por: Sulejmanpasic, Gorana, et al.
Publicado: (2017)

Onset of efficacy and duration of response of galcanezumab for the prevention of episodic migraine: a post-hoc analysis
por: Goadsby, Peter J, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5o59ngo7sb8dp8mon3uq6k3spr